Display options
Cite
Kanth VV, Sasikala M, Rao PN, et al. Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study. World J Hepatol. 2014;6(6):435-42doi: 10.4254/wjh.v6.i6.435.
Kanth, V. V., Sasikala, M., Rao, P. N., Steffie Avanthi, U., Rao, K. R., & Nageshwar Reddy, D. (2014). Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study. World journal of hepatology, 6(6), 435-42. https://doi.org/10.4254/wjh.v6.i6.435
Kanth, Vishnubhotla Venkata Ravi, et al. "Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study." World journal of hepatology vol. 6,6 (2014): 435-42. doi: https://doi.org/10.4254/wjh.v6.i6.435
Kanth VV, Sasikala M, Rao PN, Steffie Avanthi U, Rao KR, Nageshwar Reddy D. Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study. World J Hepatol. 2014 Jun 27;6(6):435-42. doi: 10.4254/wjh.v6.i6.435. PMID: 25018854; PMCID: PMC4081618.
Copy Download .nbib Format: NLM
Share it on

World J Hepatol. 2014 Jun 27;6(6):435-42. doi: 10.4254/wjh.v6.i6.435.

Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.

World journal of hepatology

Vishnubhotla Venkata Ravi Kanth, Mitnala Sasikala, Padaki Nagaraja Rao, Urmila Steffie Avanthi, Kalashikam Rajender Rao, Duvvuru Nageshwar Reddy

Affiliations

  1. Vishnubhotla Venkata Ravi Kanth, Mitnala Sasikala, Urmila Steffie Avanthi, Asian Healthcare Foundation, Hyderabad 500082, India.

PMID: 25018854 PMCID: PMC4081618 DOI: 10.4254/wjh.v6.i6.435

Abstract

AIM: To investigate genetic susceptibility in Indian subjects with non-alcoholic fatty liver disease (NAFLD) by performing a pooled genetic study.

METHODS: Study subjects (n = 306) were recruited and categorized into NAFLD and control groups based on ultrasound findings of fatty infiltration. Of the 306 individuals, 156 individuals had fatty infiltration and thus comprised the NAFLD group. One hundred and fifty (n = 150) individuals were normal, without fatty infiltration of the liver, comprising the control group. Blood samples, demographic and anthropometric data from the individuals were collected after obtaining informed consent. Anthropometric data, blood glucose, lipids and liver function tests were estimated using standard methods. Genome wide association studies done to date on NAFLD were identified, 19 single nucleotide polymorphisms (SNPs) were selected from these studies that were reported to be significantly associated with NAFLD and genotyping was performed on the Sequenom platform. Student's t test for continuous variables and χ(2) test was applied to variant carriers from both groups. Required corrections were applied as multiple testing was done. RESULTS The mean age of the control group was 39.78 ± 10.83 and the NAFLD group was 36.63 ± 8.20 years. The waist circumference of males and females in the control and NAFLD groups were 80.13 ± 10.35; 81.77 ± 13.65 and 94.09 ± 10.53; 92.53 ± 8.27 cms respectively. The mean triglyceride and alanine transaminase (ALT) levels in the control and NAFLD groups were 135.18 ± 7.77 mg/dL; 25.39 ± 14.73 IU/L and 184.40 ± 84.31 mg/dL; 110.20 ± 67.05 IU/L respectively. When χ(2) test was applied to the number of individuals carrying the variant risk alleles between the control and NAFLD group, a significant association was seen between rs738409 of the patatin-like phospholipase domain containing 3 (PNPLA3) gene (P = 0.001), rs2073080 of the PARVB gene (P = 0.02), rs2143571 of SAMM50 gene (P = 0.05) and rs6487679 of the pregnancy zone protein (PZP) gene (P = 0.01) with the disease. Variant single nucleotide polymorphisms (SNPs) in NCAN and PNPLA3 gene were associated with higher levels of ALT, whereas variant SNPs in APOC3, PNPLA3, EFCAB4B and COL13A1 were associated with high triglyceride levels. Apart from the above associations, rs2073080, rs343062 and rs6591182 were significantly associated with high BMI; rs2854117 and rs738409 with high triglyceride levels; and rs2073080, rs2143571, rs2228603, rs6487679 and rs738409 with high ALT levels.

CONCLUSION: Pooled genetic analysis revealed an association of SNPs in PNPLA3, PARVB, SAMM50 and PZP genes with NAFLD. SNPs in NCAN and PNPLA3 gene were associated with higher levels of ALT, whereas variant SNPs in APOC3, PNPLA3, EFCAB4B and COL13A1 were associated with high triglyceride levels.

Keywords: Genetic association; Genome wide association studies; Genotyping; Hepatic steatosis; Non-alcoholic fatty liver disease; Single nucleotide polymorphisms; Susceptibility

References

  1. Lancet. 2004 Jan 10;363(9403):157-63 - PubMed
  2. Gastroenterology. 2010 Nov;139(5):1567-76, 1576.e1-6 - PubMed
  3. PLoS Genet. 2011 Mar;7(3):e1001324 - PubMed
  4. J Cell Sci. 2001 Feb;114(Pt 3):525-38 - PubMed
  5. Ann Hepatol. 2007 Jul-Sep;6(3):161-3 - PubMed
  6. J Assoc Physicians India. 2009 Mar;57:201-4 - PubMed
  7. Indian J Gastroenterol. 2010 Nov;29(6):217-25 - PubMed
  8. Trop Gastroenterol. 2004 Apr-Jun;25(2):76-9 - PubMed
  9. Gastroenterology. 2009 May;136(5):1585-92 - PubMed
  10. N Engl J Med. 2010 Mar 25;362(12):1082-9 - PubMed
  11. Indian J Endocrinol Metab. 2013 Jul;17(4):665-71 - PubMed
  12. FASEB J. 2003 Aug;17(11):1559-61 - PubMed
  13. Diabetes Res Clin Pract. 2009 Apr;84(1):84-91 - PubMed
  14. J Gastroenterol Hepatol. 2011 Feb;26(2):292-9 - PubMed
  15. Metab Syndr Relat Disord. 2013 Oct;11(5):329-35 - PubMed
  16. J Assoc Physicians India. 2011 Jun;59:351-4 - PubMed
  17. Hum Genet. 2013 Jul;132(7):783-92 - PubMed
  18. Gastroenterology. 2002 Nov;123(5):1705-25 - PubMed
  19. J Biol Chem. 2005 Mar 25;280(12):11535-43 - PubMed
  20. Nat Genet. 2008 Dec;40(12):1461-5 - PubMed
  21. Gastroenterology. 2012 Jun;142(7):1592-609 - PubMed
  22. PLoS One. 2012;7(6):e38322 - PubMed
  23. Liver Int. 2011 Mar;31(3):412-6 - PubMed
  24. Hepatology. 2010 Sep;52(3):904-12 - PubMed
  25. Hepatology. 2011 Sep 2;54(3):1082-1090 - PubMed

Publication Types